Cathie's Ark Logo
undefined Logo

ARKG Holdings of Verve Therapeutics (VERV) - Updated Daily

Gene TherapyGenomicsCRSPR Gene Editing
Morning Brew Icon
China's One Ocean Problem
Date
Direction
Shares
Fund Weight
Fund
April 4, 2024
BUY43.182k0.0251%ARKG
April 3, 2024
BUY38.546k0.0217%ARKG
April 2, 2024
BUY100.614k0.0497%ARKG
February 13, 2024
BUY3.009k0.0019%ARKG
February 8, 2024
BUY1.318k0.0008%ARKG

Key Statistics

⚖️Weighting🧢Market Cap
1.54%$575.30m
🏋🏿‍♂️Weight Rank In ARKG🌏Country
25🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
46$37.81
🎫ARK Ownership Percent
3.61%

Other ETFs That Hold VERV

Ticker
NameWeight
ARKGARK Genomic Revolution ETF2.46%
GNOMGlobal X Genomics & Biotechnology ETF1.1%
XBISPDR® S&P Biotech ETF0.82%
ARKKARK Innovation ETF0.36%
LABUS&P Biotech Bull 3X Shares ETF0.124%
IBBiShares Biotechnology ETF0.07%

Research Notes and Commentary for VERV

No Research Notes Found for VERV